Plain-English translation of NCT07620834 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a new artificial intelligence tool designed to help doctors better diagnose bone weakness (osteoporosis) in people who are at high risk. About half of participants will receive the AI-guided diagnosis, while the other half will receive standard bone health screening. The study wants to see whether the AI tool can more accurately identify who has bone weakness and whether it helps make healthcare decisions better.
Osteoporosis is a silent disease where bones become weaker over time, and many people don't know they have it until they break a bone. This trial exists to see whether using artificial intelligence can catch bone weakness earlier and more accurately than current standard screening methods, especially for people at higher risk.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will be randomly assigned to either the AI-guided diagnosis group or the standard care group. Your main role will be to complete the bone health assessment assigned to your group and allow the researchers to collect information about the results and how well each approach works. The study involves multiple hospitals across Taiwan working together, so you may be able to participate at a location convenient to you.
AI-generated summary from trial data ยท Jun 6, 2026 ยท Not medical advice
Taiwan